Literature DB >> 16910414

[The carpal tunnel syndrome: medical and economic advantages of well-timed surgical treatment].

Ranko Bilić1, Robert Kolundzić, Vladimir Trkulja, Tomislav Crnković, Ana Vuković.   

Abstract

Carpal tunnel syndrome (CTS) is a somewhat neglected medical and economic problem, and surgery is one of the therapeutic options. We analyze the outcomes of surgical treatment in 114 consecutive patients (154 hands). Before the surgery, physical therapy was implemented (96% cases) and the patients were frequently on a sick leave (42% cases). Immediately before the surgery, the patients suffered intensive pain (median 7 on a 0-10 scale), and had a reduced hand function (median 2 on a 0-10 scale). After the surgery (6-12 months), the pain was reduced (difference -5.0, 95% CL -5.5, -4.5, p<0.001), and the function improved (difference 4.5, 95% CLs 4.0, 5.0, p<0.001). Longer time interval between referral to a primary care physician and referral to an orthopeadic surgeon (>1 year in 48% of the cases) was an independent negative predictor for these outcomes. Total difference in costs for sick leaves and physical therapies between the pre- and postoperative periods was estimated at approximately 269.030,00 to over 375.315,00 euros. The time between the entrance into the healthcare system and recognition of the need for surgical treatment of CTS needs to be reduced in order to get better medical and economic results.

Entities:  

Mesh:

Year:  2006        PMID: 16910414

Source DB:  PubMed          Journal:  Lijec Vjesn        ISSN: 0024-3477


  2 in total

1.  Carpal tunnel and median nerve volume changes after tunnel release in patients with the carpal tunnel syndrome: a magnetic resonance imaging (MRI) study.

Authors:  T Crnković; V Trkulja; R Bilić; D Gašpar; R Kolundžić
Journal:  Int Orthop       Date:  2015-11-23       Impact factor: 3.075

2.  The effect of epineurotomy on the median nerve volume after the carpal tunnel release: a prospective randomised double-blind controlled trial.

Authors:  Tomislav Crnković; Ranko Bilić; Vladimir Trkulja; Marijan Cesarik; Nikola Gotovac; Robert Kolundžić
Journal:  Int Orthop       Date:  2012-05-17       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.